Newsletter | October 3, 2025

10.03.25 -- STREAM Edition: How J&J Is Tackling Alzheimer's Disease

Combination Products: Navigating Regulatory Strategy, Design Verification

Webinar | West Pharmaceutical Services, Inc.

Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.

Accelerating mAb Process Development In The Growing Therapeutics Market

Webinar | Thermo Fisher Scientific

The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.

Building Better BioTherapeutics Using Machine Learning, Synthetic Biology

Webinar | ATUM

Learn about high throughput biologic automation and GMP master cell banking services as well as variable selection services that search the SQL space to find promoters.

How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

Embedded Video | Bioprocess Online

Fiona Elwood, Ph.D., VP and Neurodegeneration Disease Area Stronghold Leader at Johnson & Johnson, explains the company’s modality-agnostic approach to treating Alzheimer’s disease in this episode of Better Biopharma.

Nurturing A CDMO Relationship And Scaling Up With Amber Salzman, Ph.D.

Video | 

Epic Bio's Amber Salzman highlights the crucial role a strong CDMO partnership had in the company's manufacturing process and discusses how Epic's CMC lead was able to foster a strong partnership by treating the CDMO as an integral part of the team and showing mutual respect.

What Is The Biggest Problem With Inspector Training And Qualification?

Video | InQuest Science

Discover how a truly blind system eliminates bias from the human inspection process, improving data accuracy and validation of automated inspection systems.